Based upon trough levels of the principal active metabolite,6-thioguanine nucleotides ( 6-TGN ) , a relative bioavailability of the liquid vs. capsules of 1.01 was found ( 90 % CI 0.86 - 1.20 ) , demonstrating bioequivalence .